4//SEC Filing
Lev Pharmaceuticals Inc 4
Accession 0001144204-06-025315
CIK 0001144062operating
Filed
Jun 18, 8:00 PM ET
Accepted
Jun 19, 4:22 PM ET
Size
7.4 KB
Accession
0001144204-06-025315
Insider Transaction Report
Form 4
SCHEIN JOSHUA D
DirectorCEO10% Owner
Transactions
- Purchase
Common Stock
2006-06-15$0.57/sh+1,000$570→ 997,005 total - Purchase
Common Stock
2006-06-16$0.57/sh+1,000$570→ 998,005 total
Holdings
- 27,473,417(indirect: see footnote)
Common Stock
Footnotes (1)
- [F1]Consists of shares of common stock owned by Prism Ventures, a limited liability company in which Mr. Schein owns a 50% interest, and the following entities, all of which are owned by Prism Ventures, LLC: Newton Partners, LLC, Windsor Ventures, LLC, Sapphire Ventures, LLC, Tudor Technology Ventures, LLC and Entry Point Capital LLC.
Documents
Issuer
Lev Pharmaceuticals Inc
CIK 0001144062
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001144062
Filing Metadata
- Form type
- 4
- Filed
- Jun 18, 8:00 PM ET
- Accepted
- Jun 19, 4:22 PM ET
- Size
- 7.4 KB